CHICAGO, Dec. 3, 2014 /PRNewswire/ -- Effectively
combatting a leading form of cancer in women today requires
empowered patients, enabled clinicians, pioneering technology – and
a personalized care plan to bring them all together. For the first
time at the Radiological Society of North
America (#RSNA14) annual meeting, GE Healthcare (NYSE: GE)
is not just envisioning, but bringing to life an interconnected,
adaptable future of breast screening and diagnosis designed to help
meet the needs of each unique woman.
Putting advanced medical insights into the hands of clinicians
and patients, GE's breast care solution helps clinicians provide
individualized screening and diagnostic options in a comprehensive
environment: 3D breast tomosynthesis, automated breast ultrasound
(ABUS), contrast-enhanced spectral mammography (CESM), molecular
breast imaging (MBI), breast magnetic resonance imaging (MRI), and
healthcare IT workflows connecting them together. A customized
combination of any or all of these offerings can help enable
confident and rapid diagnoses for women, and their unique breast
health needs.
Boca Raton Regional Hospital in Boca
Raton, Florida, is the first institution in the United States to implement GE Healthcare's
comprehensive portfolio of breast health solutions.
"Our philosophy is to have women come in for screening, receive
the right supplemental screening based on her individual needs, and
walk out with confidence in her results or a clear diagnosis that
same day," said Dr. Kathy Schilling,
medical director of Christine E. Lynn
Women's and Wellness Institute of Boca Raton Regional
Hospital. "Based on individualized needs, our patients now have
access to GE Healthcare's 3D tomosynthesis, advanced mammography,
SensorySuite, CESM, ABUS, breast MRI, and MBI – all tied together
by GE's Centricity* Solutions for Enterprise Imaging software. By
offering one comprehensive solution in one place, we
want to provide one day diagnoses for more patient-centered
care."
At the core of GE Healthcare's breast care continuum are two
exceptional technologies unveiled earlier this year: SenoClaire*
and Invenia ABUS. SenoClaire, a leading 3D breast tomosynthesis
solution, helps clinicians find cancers in women with all types of
breast tissue. With no increase in radiation dose compared to a
standard 2D mammogram, SenoClaire uses a "step-and-shoot" method
that reduces blur and increases image sharpness. Invenia ABUS is
the only technology approved by the FDA for screening the 40
percent of American women who have dense breast tissue. A
first-of-its-kind study published recently in "Radiology" concluded
that screening with ABUS in women with dense breasts improves
breast cancer detection by an average of 27 percent over
mammography alone1.
GE Healthcare's solution is the only to offer 3D imaging and
ABUS, which provides clinicians with innovative tools to meet the
unique needs of women with all tissue types and nearly half the
female population with dense breasts.
"As a woman and a radiologist, I can tell you that every woman's
breast health needs are as unique as she is," said Jessie Jacob, MD, MMM, chief medical officer of
Breast Health at GE Healthcare. "It is time we break down barriers
by handing clinicians one interconnected solution that cuts across
breast care products: a comprehensive portfolio that adapts quickly
to meet the needs of each unique woman. This future starts
today."
*Trademark of the General Electric Company
¹Assessing Improvement in Detection of Breast Cancer with
Three-dimensional Automated Breast US in Women with Dense Breast
Tissue: The SomoInsight Study. Rachel F.
Brem, MD, Laszlo Tabar, MD,
Stephen W. Duffy, MSc, Marc F. Inciardi, MD, Jessica A. Guingrich, MD, Beverly E. Hashimoto, MD, Marla R. Lander, MD, Robert L. Lapidus, MD, Mary Kay Peterson, MD, Jocelyn A. Rapelyea, MD, Susan Roux, MD, Kathy J.
Schilling, MD, Biren A. Shah,
MD, Jessica Torrente, MD,
Ralph T. Wynn, MD, Dave P. Miller, MS
GE Healthcare at #RSNA14
Each year in Chicago, the conference of the Radiological
Society of North America (RSNA)
provides a forum for showcasing the latest innovations in medical
imaging. If you are attending the conference, please visit GE
Healthcare at booth number 4039 in McCormick Place south hall.
Throughout the week of the event, GE Healthcare will distribute
news and information using these digital platforms:
- Digital Press Kit: http://invent.ge/RSNA14
- Facebook: https://www.facebook.com/GEHealthcare
- Flickr: https://www.flickr.com/photos/gehealthcare
- Instagram: http://instagram.com/gehealthcare
- LinkedIn:
http://www.linkedin.com/company/gehealthcare
- Tumblr: http://gehealthcare.tumblr.com/
- Twitter: http://twitter.com/gehealthcare
- YouTube: http://www.youtube.com/user/gehealthcare
About GE Healthcare
GE Healthcare provides
transformational medical technologies and services to meet the
demand for increased access, enhanced quality and more affordable
healthcare around the world. GE (NYSE: GE) works on things that
matter - great people and technologies taking on tough challenges.
From medical imaging, software & IT, patient monitoring and
diagnostics to drug discovery, biopharmaceutical manufacturing
technologies and performance improvement solutions, GE Healthcare
helps medical professionals deliver great healthcare to their
patients. For more information about GE Healthcare, visit our
website at www.gehealthcare.com.
Photo - http://photos.prnewswire.com/prnh/20141130/161426
Photo - http://photos.prnewswire.com/prnh/20141130/161425
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/one-solution-one-stop-one-day-diagnosis-different-tests-for-different-breasts-ge-healthcares-breast-care-solution-adapts-to-individual-patient-needs-like-never-before-300004160.html
SOURCE GE Healthcare